Peanut Oral Immunotherapy in Children
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Peanut Oral Immunotherapy in Children is a clinical trial[1].
Key Facts
- Peanut Oral Immunotherapy in Children is in the country of United States[2].
- Peanut Oral Immunotherapy in Children's instance of is recorded as clinical trial[3].
- Peanut Oral Immunotherapy in Children's start time is recorded as +2013-08-13T00:00:00Z[4].
- Peanut Oral Immunotherapy in Children's end time is recorded as +2018-07-02T00:00:00Z[5].
- Peanut Oral Immunotherapy in Children's main subject is recorded as hypersensitivity[6].
- Peanut Oral Immunotherapy in Children's number of participants is recorded as {'unit': '1', 'amount': '+146'}[7].
- Peanut Oral Immunotherapy in Children's title is recorded as Oral Immunotherapy for Induction of Tolerance and Desensitization in Peanut-Allergic Children (ITN050AD)[8].
- Peanut Oral Immunotherapy in Children's short name is recorded as IMPACT[9].
- Peanut Oral Immunotherapy in Children's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q5151', 'amount': '+12'}[10].
- Peanut Oral Immunotherapy in Children's ClinicalTrials.gov ID is recorded as NCT01867671[11].
- Peanut Oral Immunotherapy in Children's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q5151', 'amount': '+48'}[12].
- Peanut Oral Immunotherapy in Children's research intervention is recorded as immunologic factor[13].
- Peanut Oral Immunotherapy in Children's clinical trial phase is recorded as phase II clinical trial[14].
- Peanut Oral Immunotherapy in Children's research site is recorded as Icahn School of Medicine at Mount Sinai[15].
- Peanut Oral Immunotherapy in Children's research site is recorded as University of North Carolina at Chapel Hill[16].
- Peanut Oral Immunotherapy in Children's study type is recorded as interventional study[17].